All Stories

  1. PseudoVelo: Inferring Gene Expression Derivatives Along Pseudotime as Pseudo-Velocity
  2. Pt-seq unveils the genomic binding pattern of platinum-based drugs
  3. Agonists and Inhibitors of the cGAS-STING Pathway
  4. Monofunctional Platinum(II) Anticancer Agents
  5. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents
  6. Specific self-monitoring of metal-associated amyloid-β peptide disaggregation by a fluorescent chelator
  7. A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease
  8. Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy
  9. Glutathione boosting the cytotoxicity of a magnetic platinum(iv) nano-prodrug in tumor cells
  10. Sequence-specific detection of cytosine methylation in DNA via the FRET mechanism between upconversion nanoparticles and gold nanorods
  11. Functionalization of Platinum Complexes for Biomedical Applications
  12. A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells
  13. Platinum(II)-Gadolinium(III) Complexes as Potential Single-Molecular Theranostic Agents for Cancer Treatment
  14. A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action
  15. Improving nuclease activity of copper(II)–terpyridine complex through solubilizing and charge effects of glycine
  16. Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles
  17. Targeting and delivery of platinum-based anticancer drugs
  18. A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles
  19. Specific recognition of DNA depurination by a luminescent terbium(iii) complex
  20. Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation
  21. Cytotoxic palladium(II) complexes of 8-aminoquinoline derivatives and the interaction with human serum albumin
  22. Noncovalent Interactions between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin
  23. New Trends and Future Developments of Platinum‐Based Antitumor Drugs
  24. Terbium(iii) complex as a luminescent sensor for human serum albumin in aqueous solution
  25. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: Distribution in tumour cells
  26. Superparamagnetic magnetite nanocrystal clusters as potential magnetic carriers for the delivery of platinum anticancer drugs
  27. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes
  28. Fast cleavage of a diselenide induced by a platinum(II)–methionine complex and its biological implications
  29. Reversible DNA Condensation Induced by a Tetranuclear Nickel(II) Complex
  30. Promotive Effect of the Platinum Moiety on the DNA Cleavage Activity of Copper-Based Artificial Nucleases
  31. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin
  32. Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and Neurotoxicity
  33. Fabrication of water soluble and biocompatible CdSe nanoparticles in apoferritin with the aid of EDTA
  34. Comparison of DNA binding and cleavage abilities between mono- and trinuclear copper(II) complexes of benzimidazole derivatives
  35. Recognition of phosphate anions in aqueous solution by a dinuclear zinc(II) complex of a cyclen-tethered terpyridine ligand
  36. Targeted binding of a platinum(II)–methionine complex to the disulfide linkage of a nonapeptide oxytocin
  37. Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
  38. Selective guanosine binding and cytotoxicity of a benzimidazole derived dinickel complex
  39. A Trinuclear Copper(II) Complex of 2,4,6-Tris(di-2-pyridylamine)-1,3,5-triazine Shows Prominent DNA Cleavage Activity
  40. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity
  41. Encapsulation of platinum anticancer drugs by apoferritin
  42. Selective sensing of dihydrogen phosphate anion by a fluorescent tetranuclear pentacoordinated zinc(ii) complex
  43. The Role of Sulfur in Platinum Anticancer Chemotherapy
  44. Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules
  45. Disulfide Bond Cleavage Induced by a Platinum(II) Methionine Complex
  46. An Asymmetric Dizinc Phosphodiesterase Model with Phenolate and Carboxylate Bridges
  47. Crystal structure, DNA-binding ability and cytotoxic activity of platinum(II) 2,2′-dipyridylamine complexes
  48. Monofunctional Platinum Complexes Showing Potent Cytotoxicity against Human Liver Carcinoma Cell Line BEL-7402
  49. 5-Fluorouracil–cisplatin adducts with potential antitumor activity
  50. DNA-binding property and antitumor activity of bismuth(iii) complex with 1,4,7,10-tetrakis(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecaneElectronic supplementary information (ESI) available: 1H-NMR, ES-MS and CD spectra. See http://www.rsc.org/suppdat...